PlainRecalls
FDA Drug Low Class III Terminated

Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06

Reported: November 22, 2017 Initiated: October 30, 2017 #D-0082-2018

Product Description

Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06

Reason for Recall

Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Details

Units Affected
744 bottles
Distribution
Nationwide
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 744 bottles.
Why was this product recalled?
Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 22, 2017. Severity: Low. Recall number: D-0082-2018.